City of Hope Opens Trial to Test Bone Medication for Early Type 1 Diabetes Treatment
City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...
The American Journal of Managed Care17h
Dr Toon Van Gorp: Mirvetuximab Soravtansine Should Be Global Standard for FRα+ Ovarian Cancer
Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...
Novartis5h
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
Optometry Advisor15h
GLP-1 Drugs Associated With a Reduced Risk of Multiple Age-Related Ocular Diseases
Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.